Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

f8fb92cf1.CAPPTowjmpHyN8G3cVqXnYl5lCzptPa4Ne6AjSzvDJQ.PnGAILlW3OKcc57vGx_w6uJK_HmYw8b6fa_2yUaDecdCVfkEwWD22sRolA~283989c213596656472ef9a92fd162a7
08/07 Forvia holds up thanks to Citi upgrade Zonebourse
01/07 Deutsche Bank Cuts Its Target on Forvia Zonebourse
26/06 Forvia keeps sliding despite Jefferies' positive view Zonebourse
30/04 Forvia: EPS cut (2025: from € -0.46 to -7.78, 2026: from € 1.22 to 0.88) Alphavalue
28/04 Jefferies applauds divestment of Forvia's Interiors business Zonebourse
08/04 Berenberg Updates Forvia Model After Q1 Pre-close Call; Price Target Cut on Sector De-rating MT
07/04 Forvia in the red as Berenberg forecasts 24% revenue drop for Q1 Zonebourse
11/03 Forvia slips despite support from Citigroup Zonebourse
04/03 Forvia: Resilient FY25 in a Tough Environment; Ambitious 2028 Targets Unveiled at CMD Alphavalue
26/02 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
20/01 Forvia lifts EPS after Q4 pre-close Alphavalue
25/11 Forvia revises EPS outlook after non-cash charge Alphavalue
21/25/21 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
21/25/21 Forvia: UBS still neutral after quarterly results Zonebourse
20/25/20 Forvia: Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
12/25/12 The stock market regains its cloak of invincibility Zonebourse
07/25/07 Forvia: Opinion change, from Sell to Reduce Alphavalue
30/25/30 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
29/25/29 Forvia: Deutsche Bank downgrades stock Zonebourse
29/25/29 Forvia: Solid H1 results ahead of expectations, FY25 guidance confirmed Alphavalue
29/25/29 Forvia: Oddo BHF raises target price Zonebourse
24/25/24 Forvia: NAV cut by -14.8% Alphavalue
03/25/03 Forvia: Target upgrade by 14.5% Alphavalue
27/25/27 Forvia: Berenberg still a buyer, seeing positive surprises Zonebourse
22/25/22 FORVIA : Receives a Buy rating from Deutsche Bank ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+57.12%
+49.17%
+37.12%
+9.26%
+42.16%
+39.47%
-2.08%
+5.78%
+8.45%
+27.81%
Average +27.43%
Weighted average by Cap. +28.96%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.282EUR
Average target price
14.68EUR
Spread / Average Target
+58.14%
High Price Target
39.00EUR
Spread / Highest target
+320.17%
Low Price Target
10.50EUR
Spread / Lowest Target
+13.12%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Adrien Brasey
TP ICAP Midcap
UBS David Lesne
Stifel Nicolaus
Berenberg Bank
GOLDMAN SACHS Philipp Konig
JEFFERIES Himanshu Agarwal
DEUTSCHE BANK RESEARCH Christoph Laskawi
JPMORGAN Jose Asumendi
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.282EUR
Average target price
14.68EUR
Spread / Average Target
+58.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)